36 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Author: Lisa Levin | March 04, 2020 09:00am

Gainers

SINTX Technologies, Inc. (NASDAQ:SINT) shares increased by 34.1% to $0.88 during Wednesday's pre-market session.
Arcturus Therapeutics, Inc. (NASDAQ:ARCT) shares increased by 26.9% to $18.40. The most recent rating by Baird, on February 11, is at Outperform, with a price target of $24.00.
Dynatronics, Inc. (NASDAQ:DYNT) stock rose 20.9% to $2.14.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock increased by 20.8% to $9.00. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
Vir Biotechnology, Inc. (NASDAQ:VIR) shares increased by 14.9% to $47.06. The most recent rating by JP Morgan, on February 04, is at Neutral, with a price target of $26.00.
UnitedHealth Group, Inc. (NYSE:UNH) shares rose 9.5% to $286.04. The most recent rating by Deutsche Bank, on February 18, is at Hold, with a price target of $362.00.
Anthem, Inc. (NYSE:ANTM) stock rose 9.2% to $280.00. The most recent rating by Deutsche Bank, on February 18, is at Buy, with a price target of $362.00.
GenMark Diagnostics, Inc. (NASDAQ:GNMK) shares surged 8.5% to $4.65. The most recent rating by Needham, on March 03, is at Buy, with a price target of $11.00.
Cigna, Inc. (NYSE:CI) stock surged 8.4% to $205.00. The most recent rating by Piper Sandler, on February 25, is at Overweight, with a price target of $240.00.
Zosano Pharma, Inc. (NASDAQ:ZSAN) stock rose 8.4% to $0.95.
Centene, Inc. (NYSE:CNC) shares increased by 8.2% to $58.50. The most recent rating by Deutsche Bank, on February 18, is at Buy, with a price target of $84.00.
Schrodinger, Inc. (NASDAQ:SDGR) shares surged 5.9% to $41.85.
NuCana, Inc. (NASDAQ:NCNA) shares moved upwards by 5.7% to $8.30.
InflaRx, Inc. (NASDAQ:IFRX) shares surged 5.7% to $4.85.
Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) shares moved upwards by 5.4% to $26.00. The most recent rating by Barclays, on March 04, is at Overweight, with a price target of $30.00.
Mallinckrodt, Inc. (NYSE:MNK) stock surged 5.1% to $3.30. The most recent rating by B of A Securities, on February 26, is at Underperform, with a price target of $3.00.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stock rose 4.8% to $2.20.
CVS Health, Inc. (NYSE:CVS) shares increased by 4.8% to $65.50. The most recent rating by Deutsche Bank, on February 18, is at Buy, with a price target of $109.00.
Rite Aid, Inc. (NYSE:RAD) stock increased by 4.6% to $17.30.
Cronos Group, Inc. (NASDAQ:CRON) stock surged 4.5% to $5.56.
AstraZeneca, Inc. (NYSE:AZN) stock surged 4.3% to $47.48.
Sanofi, Inc. (NASDAQ:SNY) stock moved upwards by 3.8% to $49.53. The most recent rating by Argus Research, on February 19, is at Buy, with a price target of $56.00.
Health Insurance, Inc. (NASDAQ:HIIQ) stock increased by 3.4% to $29.04. The most recent rating by Cantor Fitzgerald, on March 04, is at Overweight, with a price target of $75.00.
Novartis, Inc. (NYSE:NVS) stock moved upwards by 3.4% to $86.37. According to the most recent rating by Guggenheim Securities, on February 25, the current rating is at Neutral.
Amarin Corp, Inc. (NASDAQ:AMRN) shares increased by 3.4% to $16.06. The most recent rating by Cowen & Co., on March 02, is at Outperform, with a price target of $23.00.

Losers

Allied Healthcare Prods, Inc. (NASDAQ:AHPI) stock plummeted 20.2% to $15.95 during Wednesday's pre-market session.
Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) shares decreased by 10.5% to $0.42.
Co-Diagnostics, Inc. (NASDAQ:CODX) stock fell 8.6% to $13.12. According to the most recent rating by Maxim Group, on March 03, the current rating is at Hold.
Stealth BioTherapeutics, Inc. (NASDAQ:MITO) stock fell 5.9% to $2.89. According to the most recent rating by H.C. Wainwright, on December 23, the current rating is at Neutral.
Vaxart, Inc. (NASDAQ:VXRT) stock plummeted 5.6% to $2.04.
Novan, Inc. (NASDAQ:NOVN) stock decreased by 5.4% to $0.35. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
Guardion Health Sciences, Inc. (NASDAQ:GHSI) shares plummeted 4.6% to $0.39.
OpGen, Inc. (NASDAQ:OPGN) stock decreased by 4.3% to $3.75.
Heat Biologics, Inc. (NASDAQ:HTBX) stock fell 3.9% to $0.58. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.
Novavax, Inc. (NASDAQ:NVAX) shares declined 3.7% to $10.38. The most recent rating by B. Riley FBR, on February 28, is at Buy, with a price target of $16.00.
Altimmune, Inc. (NASDAQ:ALT) shares plummeted 3.4% to $3.15.